The findings provide novel insights into the host response to SARS-CoV-2 infection at the epigenetic level and reveal PTEN, IGF1R, MYC, and STAT3 as the most interacting genes.
Abstract
Epigenetic regulation can play a dual role in viral infection, acting as part of the host defense, while being hijacked to control viral latency, replication, and persistence. During the COVID-19 pandemic, substantial evidence indicated that different SARS-CoV-2 variants may lead to distinct outcomes by affecting different molecular pathways, including epigenetic mechanisms. In this study, we assessed miRNA expression using high-throughput microarray technology to simultaneously measure the expression of thousands of miRNAs. We focused on: comparing Delta and Omicron infections with healthy controls; identifying specific miRNAs linked to symptom severity; analyzing miRNA expression across different stages of Delta variant infection; and predicting miRNA target genes and evaluating miRNA–mRNA interactions. We identified 65 miRNAs that were significantly differentially expressed simultaneously in both SARS-CoV-2 variants compared to healthy samples. These miRNAs were categorized into distinct functional groups based on their roles in viral infection. We observed an association between the expression of specific miRNAs and virus-induced symptom severity and patients’ outcomes in both variants. Furthermore, we examined miRNA expression across the various phases of the Delta variant and identified 38 miRNAs that were significantly differentially expressed. Finally, mRNA-miRNA interaction analysis revealed PTEN, IGF1R, MYC, and STAT3 as the most interacting genes. Profiling thousands of miRNAs in response to different SARS-CoV-2 variants offers new opportunities for diagnosis, prognosis, and therapy. Although comorbidities and pathway cross-talk may influence the obtained results, our findings provide novel insights into the host response to SARS-CoV-2 infection at the epigenetic level.
Post-COVID-19 syndrome (PC) is defined by the persistence of symptoms over 12 weeks after infection with SARS-CoV-2, without any other diagnosis. These symptoms can affect multiple systems with neurological, hemodynamic, and respiratory disorders. Exacerbated activation of the innate immune response mediated by cytokin...
L. da Silva, F. Corrêa, M. D. Carvalho et al.· medRxiv· 0 citations
These findings identify ORF8 as a factor associated with coordinated miRNA-mediated post-transcriptional reprogramming in lung epithelial cells and provides new insight into how SARS-CoV-2 accessory proteins may influence host responses and highlights miRNA networks as potential contributors to viral pathogenesis and h...
Raúl Fernández-Rodríguez, José M. Suárez-Cárdenas, Antonio Romero-Guillén et al.· International Journal of Mol...· 0 citations
It is posited that miRNAs hold significant potential both as novel therapeutic targets and as pivotal regulators in deciphering the intricate pathogenesis of COVID-19 and requires the synergistic integration of in vivo and in vitro experimental approaches in conjunction with rigorous clinical investigations.
Gokce Kader Arslan, Mehmet Özdemir· Microorganisms· 0 citations
Introduction While microRNA (miR) expression profiling has identified potential biomarkers in patients with COVID-19, the regulatory mechanisms by which miRs modulate disease severity remain poorly characterized. We performed integrated miR–proteome analysis to elucidate mechanistic relationships between miR regulation...
Kelly E. Mercer, Vikrant Vijay, Li-Rong Yu et al.· Frontiers in Immunology· 0 citations
The miRNA-virus axis is reinterprets as a dynamic regulatory network and provides a translational framework for the development of next-generation antiviral therapeutics.
Dakshina M. Nair, L. Vajravelu, Rahul Harikumar Lathakumari et al.· Microbial Pathogenesis· 0 citations
The biogenesis and biological functions of miRNAs are discussed and their regulatory roles in the pathogenesis of rheumatoid arthritis, inflammatory bowel disease, multiple sclerosis, multiple sclerosis, psoriasis, systemic lupus erythematosus, and atopic dermatitis are examined.
T. Tunç, Serap Yaman Ozer, Sema Mısır· Frontiers in Immunology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.